KNE Insider Trading

Insider Ownership Percentage: 37.21%
Insider Buying (Last 12 Months): C$79,800.00
Insider Selling (Last 12 Months): C$260,000.00

Kane Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Kane Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025C$0boughtC$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-C$200k-C$100kC$0C$100kC$200kTotal Insider BuyingTotal Insider Selling

Kane Biotech Share Price & Price History

Current Price: C$0.10
Price Change: +0.30 (1.20%)
As of 01/17/2025 12:12 PM ET

This chart shows the closing price history over time for KNE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJanC$0.10Closing price on 01/19/25:

Kane Biotech Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Kane Biotech (CVE:KNE)

Kane Biotech logo
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Read More on Kane Biotech

Today's Range

Now: C$0.10
Low: C$0.10
High: C$0.11

50 Day Range

MA: C$0.11
Low: C$0.10
High: C$0.13

52 Week Range

Now: C$0.10
Low: C$0.08
High: C$0.17

Volume

2,500 shs

Average Volume

91,315 shs

Market Capitalization

C$13.25 million

P/E Ratio

N/A

Dividend Yield

3.08%

Beta

0.52

Who are the company insiders with the largest holdings of Kane Biotech?

Kane Biotech's top insider investors include:
  1. Marc Edwards (Director)
  2. Philip Renaud (Director)
  3. Richard J Renaud (Insider)
  4. Robert Huizinga (Director)
Learn More about top insider investors at Kane Biotech.